Hyperkalemia caused by Qingfei Paidu decoction() in a patient with novel coronavirus pneumonia.
Adverse Drug Reactions Journal
; 22(6):375-376, 2020.
Article
in Chinese
| EMBASE | ID: covidwho-2296130
ABSTRACT
A 23-year-old male patient received moxifloxacin, recombinant human interferon alpha-2b for injection, and lopinavir and ritonavir for 7 days for novel coronavirus pneumonia. There was no abnor-malityof serum potassium. Moxifloxacin was stopped, Qingfei Paidu decoction() was given, and then the patient's serum potassium began to rise. On day 10 after taking the decoction, laboratory tests showed serum potassium 5.7 mmol/L and the patient was diagnosed with hyperkalemia. Insulin injection 4 U diluted to 5% glucose injection 250 ml was given once by IV infusion, and then the serum potassium decreased to 5.0 mmol/L 6 hours later and 4.6 mmol/L 2 days later. After 5 days, the serum potassium rose again and finally to 5.4 mmol/L on day 17 after taking the decoction. Insulin was given once that day and 2 days later once daily according to the previous method. Then the serum potassium decreased and did not rise again. The patient recovered from novel coronavirus pneumonia and was discharged on day 28 after hospitalization.Copyright © 2020 by the Chinese Medical Association.
Coronavirus infections; Hyperkalemia; Medicine; Chinese traditional; Qingfei Paidu decoction (); adult; article; case report; clinical article; coronavirus disease 2019/dt [Drug Therapy]; hospitalization; human; hyperkalemia/si [Side Effect]; injection; laboratory test; male; potassium blood level; priority journal; young adult; alpha2b interferon/dt [Drug Therapy]; Chinese drug/ae [Adverse Drug Reaction]; Chinese drug/dt [Drug Therapy]; insulin/iv [Intravenous Drug Administration]; lopinavir/dt [Drug Therapy]; moxifloxacin/dt [Drug Therapy]; potassium; ritonavir/dt [Drug Therapy]; unclassified drug; qingfei paidu decoction/ae [Adverse Drug Reaction]; qingfei paidu decoction/dt [Drug Therapy]
Full text:
Available
Collection:
Databases of international organizations
Database:
EMBASE
Language:
Chinese
Journal:
Adverse Drug Reactions Journal
Year:
2020
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS